{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T09:09:59Z","timestamp":1760346599965},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,3,24]],"date-time":"2017-03-24T00:00:00Z","timestamp":1490313600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Susan G. Komen for the Cure (US)","award":["KG 110356"],"award-info":[{"award-number":["KG 110356"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s00520-017-3678-8","type":"journal-article","created":{"date-parts":[[2017,3,24]],"date-time":"2017-03-24T13:32:57Z","timestamp":1490362377000},"page":"2697-2705","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A prospective study of aromatase inhibitor therapy initiation and self-reported side effects"],"prefix":"10.1007","volume":"25","author":[{"given":"Lisa","family":"Gallicchio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Calhoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathy","family":"Helzlsouer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,3,24]]},"reference":[{"key":"3678_CR1","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1056\/NEJMoa052258","volume":"353","author":"B Thurlimann","year":"2005","unstructured":"Breast International Group 1-98 Collaborative Group, Thurlimann B, Keshaviah A, Coates AS et al (2005) A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. N Engl J Med 353:2747\u20132757","journal-title":"N Engl J Med"},{"key":"3678_CR2","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1200\/JCO.2006.08.8617","volume":"25","author":"AS Coates","year":"2007","unstructured":"Coates AS, Keshaviah A, Thurlimann B et al (2007) Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98. J Clin Oncol 25:486\u2013492","journal-title":"J Clin Oncol"},{"key":"3678_CR3","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0140-6736(07)60200-1","volume":"369","author":"RC Coombes","year":"2007","unstructured":"Coombes RC, Kilburn LS, Snowdon CF et al (2007) Survival and safety of exemestane versus tamoxifen after 2-3 years\u2019 tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial. Lancet 369:559\u2013570","journal-title":"Lancet"},{"key":"3678_CR4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1470-2045(07)70385-6","volume":"9","author":"JF Forbes","year":"2008","unstructured":"Arimidex Tamoxifen, Alone or in Combination (ATAC) Trialists\u2019 Group, Forbes JF, Cuzick J, Buzdar A, Howell A, Tobias JS, Baum M (2008) Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial. Lancet Oncol 9:45\u201353","journal-title":"Lancet Oncol"},{"key":"3678_CR5","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1634\/theoncologist.9-2-126","volume":"9","author":"SM Campos","year":"2004","unstructured":"Campos SM (2004) Aromatase inhibitors for breast cancer in postmenopausal women. Oncologist 9:126\u2013136","journal-title":"Oncologist"},{"key":"3678_CR6","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s10549-012-2114-5","volume":"134","author":"CC Murphy","year":"2012","unstructured":"Murphy CC, Bartholomew LK, Carpentier MY, Bluethmann SM, Vernon SW (2012) Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review. Breast Cancer Res Treat 134:459\u2013478","journal-title":"Breast Cancer Res Treat"},{"key":"3678_CR7","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1634\/theoncologist.2015-0349","volume":"21","author":"KC Kadakia","year":"2016","unstructured":"Kadakia KC, Snyder CF, Kidwell KM, Seewald NJ, Flockhart DA, Skaar TC, Desta Z, Rae JM, Otte JL, Carpenter JS (2016) Patient-reported outcomes and early discontinuation in aromatase inhibitor-treated postmenopausal women with early stage breast cancer. Oncologist 21:539\u2013546","journal-title":"Oncologist"},{"key":"3678_CR8","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1200\/JCO.2011.38.0261","volume":"30","author":"NL Henry","year":"2012","unstructured":"Henry NL, Azzouz F, Desta Z, Li L, Nguyen AT, Lemler S, Hayden J, Tarpinian K, Yakim E, Flockhart DA et al (2012) Predictors of aromatase inhibitor discontinuation as a result of treatment-emergent symptoms in early-stage breast cancer. J Clin Oncol 30:936\u2013942","journal-title":"J Clin Oncol"},{"key":"3678_CR9","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1200\/JCO.2007.11.5451","volume":"26","author":"AH Partridge","year":"2008","unstructured":"Partridge AH, LaFountain A, Mayer E, Taylor BS, Winer E, Asnis-Alibozek A (2008) Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer. J Clin Oncol 26:556\u2013562","journal-title":"J Clin Oncol"},{"key":"3678_CR10","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10549-011-1729-2","volume":"131","author":"KJ Helzlsouer","year":"2012","unstructured":"Helzlsouer KJ, Gallicchio L, MacDonald R, Wood B, Rushovich E (2012) A prospective study of aromatase inhibitor therapy, vitamin D, C-reactive protein and musculoskeletal symptoms. Breast Cancer Res Treat 131:277\u2013285","journal-title":"Breast Cancer Res Treat"},{"key":"3678_CR11","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1093\/annonc\/mdt037","volume":"24","author":"P Niravath","year":"2013","unstructured":"Niravath P (2013) Aromatase inhibitor-induced arthralgia: a review. Ann Oncol 24:1443\u20131449","journal-title":"Ann Oncol"},{"key":"3678_CR12","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1002\/art.21364","volume":"52","author":"DT Felson","year":"2005","unstructured":"Felson DT, Cummings SR (2005) Aromatase inhibitors and the syndrome of arthralgias with estrogen deprivation. Arthritis Rheum 52:2594\u20132598","journal-title":"Arthritis Rheum"},{"key":"3678_CR13","first-page":"1401","volume":"22","author":"NL Henry","year":"2008","unstructured":"Henry NL, Giles JT, Stearns V (2008) Aromatase inhibitor-associated musculoskeletal symptoms: etiology and strategies for management. Oncology (Williston Park) 22:1401\u20131408","journal-title":"Oncology (Williston Park)"},{"key":"3678_CR14","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1007\/s00520-015-3001-5","volume":"24","author":"JM Lombard","year":"2016","unstructured":"Lombard JM, Zdenkowski N, Wells K, Beckmore C, Reaby L, Forbes JF, Chirgwin J (2016) Aromatase inhibitor induced musculoskeletal syndrome: a significant problem with limited treatment options. Support Care Cancer 24:2139\u20132146","journal-title":"Support Care Cancer"},{"key":"3678_CR15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10549-011-1351-3","volume":"126","author":"SF Dent","year":"2011","unstructured":"Dent SF, Gaspo R, Kissner M, Pritchard KI (2011) Aromatase inhibitor therapy: toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancer. Breast Cancer Res Treat 126:295\u2013310","journal-title":"Breast Cancer Res Treat"},{"key":"3678_CR16","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1200\/JCO.2015.64.3866","volume":"34","author":"PA Ganz","year":"2016","unstructured":"Ganz PA, Petersen L, Bower JE, Crespi CM (2016) Impact of adjuvant endocrine therapy on quality of life and symptoms: observational data over 12 months from the mind-body study. J Clin Oncol 34:816\u2013824","journal-title":"J Clin Oncol"},{"key":"3678_CR17","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3109\/13697137.2011.620658","volume":"15","author":"L Gallicchio","year":"2012","unstructured":"Gallicchio L, MacDonald R, Wood B, Rushovich E, Helzlsouer KJ (2012) Menopausal-type symptoms among breast cancer patients on aromatase inhibitor therapy. Climacteric 15:339\u2013349","journal-title":"Climacteric"},{"key":"3678_CR18","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10549-013-2744-2","volume":"142","author":"L Gallicchio","year":"2013","unstructured":"Gallicchio L, Calhoun C, Helzlsouer KJ (2013) Aromatase inhibitor therapy and hair loss among breast cancer survivors. Breast Cancer Res Treat 142:435\u2013443","journal-title":"Breast Cancer Res Treat"},{"key":"3678_CR19","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1200\/JCO.2014.56.1662","volume":"32","author":"PA Ganz","year":"2014","unstructured":"Ganz PA, Petersen L, Castellon SA, Bower JE, Silverman DH, Cole SW, Irwin MR, Belin TR (2014) Cognitive function after the initiation of adjuvant endocrine therapy in early-stage breast cancer: an observational cohort study. J Clin Oncol 32:3559\u20133567","journal-title":"J Clin Oncol"},{"key":"3678_CR20","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/pon.1453","volume":"18","author":"B Collins","year":"2009","unstructured":"Collins B, Mackenzie J, Stewart A, Bielajew C, Verma S (2009) Cognitive effects of hormonal therapy in early stage breast cancer patients: a prospective study. Psychooncology 18:811\u2013821","journal-title":"Psychooncology"},{"key":"3678_CR21","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.breast.2015.08.008","volume":"24","author":"H Inglis","year":"2015","unstructured":"Inglis H, Boyle FM, Friedlander ML, Watson SL (2015) Dry eyes and AIs: if you don\u2019t ask you won\u2019t find out. Breast 24:694\u2013698","journal-title":"Breast"},{"key":"3678_CR22","doi-asserted-by":"crossref","unstructured":"Gallicchio L, Calhoun C, Riseberg D, Helzlsouer KJ (2017) Cardiovascular health among black and white breast cancer patients initiating aromatase inhibitor therapy. Breast J","DOI":"10.1111\/tbj.12709"},{"key":"3678_CR23","doi-asserted-by":"crossref","unstructured":"Merriman JD, Sereika SM, Brufsky AM, McAuliffe PF, McGuire KP, Myers JS, Phillips ML, Ryan CM, Gentry AL, Jones LD, Bender CM (2017) Trajectories of self-reported cognitive function in postmenopausal women during adjuvant systemic therapy for breast cancer. Psychooncology","DOI":"10.1002\/pon.4009"},{"key":"3678_CR24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/978-1-4613-2211-5_4","volume-title":"Advances in clinical neuropsychology. Volume 3","author":"CJ Chelune","year":"1986","unstructured":"Chelune CJ, Heaton RK, Lehman RAW (1986) Neuropsychological and personality correlates of patients\u2019 complaints of disability. In: Goldstein G, Tarter RE (eds) Advances in clinical neuropsychology. Volume 3. Plenum Press, New York, pp 95\u2013126"},{"key":"3678_CR25","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10549-015-3493-1","volume":"152","author":"E Le Rhun","year":"2015","unstructured":"Le Rhun E, Delbeuck X, Lefeuvre-Plesse C, Kramar A, Skrobala E, Pasquier F, Bonneterre J (2015) A phase III randomized multicenter trial evaluating cognition in post-menopausal breast cancer patients receiving adjuvant hormonotherapy. Breast Cancer Res Treat 152:569\u2013580","journal-title":"Breast Cancer Res Treat"},{"key":"3678_CR26","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.clbc.2013.10.010","volume":"14","author":"A Hurria","year":"2014","unstructured":"Hurria A, Patel SK, Mortimer J, Luu T, Somlo G, Katheria V, Ramani R, Hansen K, Feng T, Chuang C, Geist CL, Silverman DH (2014) The effect of aromatase inhibition on the cognitive function of older patients with breast cancer. Clin Breast Cancer 14:132\u2013140","journal-title":"Clin Breast Cancer"},{"key":"3678_CR27","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S1470-2045(08)70207-9","volume":"9","author":"VA Jenkins","year":"2008","unstructured":"Jenkins VA, Ambroisine LM, Atkins L, Cuzick J, Howell A, Fallowfield LJ (2008) Effects of anastrozole on cognitive performance in postmenopausal women: a randomised, double-blind chemoprevention trial (IBIS II). Lancet Oncol 9:953\u2013961","journal-title":"Lancet Oncol"},{"key":"3678_CR28","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/hbm.22218","volume":"35","author":"S Shanmugan","year":"2014","unstructured":"Shanmugan S, Epperson CN (2014) Estrogen and the prefrontal cortex: towards a new understanding of estrogen\u2019s effects on executive functions in the menopause transition. Hum Brain Mapp 35:847\u2013865","journal-title":"Hum Brain Mapp"},{"key":"3678_CR29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.heares.2009.09.009","volume":"259","author":"C Hederstierna","year":"2010","unstructured":"Hederstierna C, Hultcrantz M, Collins A, Rosenhall U (2010) The menopause triggers hearing decline in healthy women. Hear Res 259:31\u201335","journal-title":"Hear Res"},{"key":"3678_CR30","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10549-010-1132-4","volume":"126","author":"DL Hershman","year":"2011","unstructured":"Hershman DL, Shao T, Kushi LH, Buono D, Tsai WY, Fehrenbacher L, Kwan M, Gomez SL, Neugut AI (2011) Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat 126:529\u2013537","journal-title":"Breast Cancer Res Treat"},{"key":"3678_CR31","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1200\/JCO.2015.63.8619","volume":"34","author":"JH Chirgwin","year":"2016","unstructured":"Chirgwin JH, Giobbie-Hurder A, Coates AS et al (2016) Treatment adherence and its impact on disease-free survival in the breast international group 1-98 trial of tamoxifen and Letrozole, alone and in sequence. J Clin Oncol 34:2452\u20132459","journal-title":"J Clin Oncol"},{"key":"3678_CR32","doi-asserted-by":"crossref","first-page":"e87027","DOI":"10.1371\/journal.pone.0087027","volume":"9","author":"KP Hsieh","year":"2014","unstructured":"Hsieh KP, Chen LC, Cheung KL, Chang CS, Yang YH (2014) Interruption and non-adherence to long-term adjuvant hormone therapy is associated with adverse survival outcome of breast cancer women\u2014an Asian population-based study. PLoS One 9:e87027","journal-title":"PLoS One"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-017-3678-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-017-3678-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-017-3678-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,7,25]],"date-time":"2017-07-25T07:58:16Z","timestamp":1500969496000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-017-3678-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,24]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["3678"],"URL":"https:\/\/doi.org\/10.1007\/s00520-017-3678-8","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,24]]}}}